Sunesis Pharmaceutic (SNSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | SNSS | ETON | BTAI | ||
Company | Sunesis Pharmaceutic | Eton Pharmaceutcials Inc | Bioxcel Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 16.35 | 3.75 | 2.60 | ||
High | 24.80 | 3.80 | 2.67 | ||
Low | 16.35 | 3.61 | 2.56 | ||
Last | 18.62 | 3.71 | 2.57 | ||
Change | +3.64 | -0.04 | +0.01 | ||
% Change | +24.30% | -1.07% | +0.39% | ||
Volume | 20,069,086 | 61,000 | 147,500 | ||
20-Day Average Volume | 6,608,405 | 51,785 | 396,670 | ||
Previous Close | 14.98 | 3.75 | 2.56 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 3.35 | 3.38 | 2.67 | ||
20-Day Raw Stochastic | 62.71% | 76.40% | 11.69% | ||
20-Day Relative Strength | 78.29% | 52.14% | 44.71% | ||
Weighted Alpha | +200.53 | -13.96 | -80.53 | ||
Today's Opinion | 88% Buy | 64% Sell | 100% Sell | ||
Previous Opinion | 88% Buy | 64% Sell | 100% Sell | ||
Last Month's Opinion | 40% Buy | 40% Sell | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +35.37% since 02/17/21 | +7.54% since 04/26/24 | -2.28% since 04/26/24 | ||
Low | 3.53 on 02/22/21 | 3.41 on 04/29/24 | 2.50 on 05/02/24 | ||
High | 7.09 on 02/24/21 | 3.92 on 05/02/24 | 2.69 on 04/29/24 | ||
1-Month | |||||
%Chg | +75.58% since 01/22/21 | +3.06% since 04/03/24 | -2.65% since 04/03/24 | ||
Low | 2.35 on 01/28/21 | 3.03 on 04/17/24 | 2.50 on 05/02/24 | ||
High | 7.09 on 02/24/21 | 3.92 on 05/02/24 | 3.10 on 04/12/24 | ||
3-Month | |||||
%Chg | +291.18% since 11/24/20 | -17.37% since 02/02/24 | -16.01% since 02/02/24 | ||
Low | 1.33 on 11/25/20 | 3.03 on 04/17/24 | 1.91 on 02/09/24 | ||
High | 7.09 on 02/24/21 | 4.75 on 02/06/24 | 4.17 on 02/06/24 | ||
6-Month | |||||
%Chg | +92.27% since 08/24/20 | -18.46% since 11/03/23 | -44.61% since 11/03/23 | ||
Low | 1.12 on 11/06/20 | 3.03 on 04/17/24 | 1.91 on 02/09/24 | ||
High | 7.09 on 02/24/21 | 5.11 on 01/08/24 | 5.62 on 11/13/23 | ||
Key Statistics | |||||
Market Capitalization, $K | 96,255 | 96,330 | 94,810 | ||
Shares Outstanding, K | 18,093 | 25,688 | 37,035 | ||
Annual Sales | 2,070,000 | 31,640,000 | 1,380,000 | ||
Annual Net Income | -23,330,000 | -940,000 | -179,050,000 | ||
Last Quarter Sales | N/A | 7,310,000 | 380,000 | ||
Last Quarter Net Income | N/A | -2,260,000 | -22,260,000 | ||
60-Month Beta | 2.21 | 1.19 | 0.43 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.09 on 03/14/24 | -0.76 on 03/12/24 | ||
Latest Earnings Date | 03/09/21 | 05/09/24 | 05/09/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |